Excretion is primarily renal, with approximately 84% of an administered dose excreted in the urine (30% as the unchanged drug, 40% as Metabolite B, and 10% as Metabolite A)
However, some patients plan to lose a substantial amount of weight from their GLP-1 medication and then deliberately switch to non-medication weight management plans, consisting of regular exercise and healthy eating
Keep one agent stable while adjusting the other
For example: 200 pounds 3050 pounds 250 pounds 3863 pounds Longer-term use supports more sustained results, especially when treatment is paired with adequate protein intake, muscle preservation, and ongoing monitoring
Patients should eat slowly, chew food thoroughly, and avoid talking while eating to minimize air swallowing (aerophagia)
We are pleased to offer Semaglutide, a treatment that has made weight loss solutions more accessible